Unilens Vision (fka UVIC)

[MikeDDKing]

I read the wrong line which wasn't actually LIBOR. My guess is they use the 1 Year LIBOR Rate which is 1.01%. They don't state which LIBOR rate in the filing so I'm assuming the longest one which also would make the most sense since it is a 5 year loan.

If my assumption is correct that means to start with we get the minimum interest rate of 4.75% which is awesome!

The following web page has the LIBOR rates as of yesterday:
http://online.wsj.com/mdc/public/page/2_3020-moneyrate.html?mod=mdc_bnd_pglnk

[ghmm]

I found that link too after the filing but it wasn't clear to me if that is the rate or it is much lower (.24) though we would pay the minimum. Don't recall in my scan of the docs if it said which LIBOR rate. I am not a banker nor familiar with LIBOR but thought it would be adjusted monthly so the monthly rate would be used. Just my 2 cent guess.

[SSKILLZ1]

Yes I was figuring 10-12%, so I'm happy with the numbers.

[MikeDDKing]

According to Bankrate, Libor is 4.33% as of 11/24/09. That makes the interest rate 7.58-8.08%. I'm quite happy with that rate.

http://www.bankrate.com/rates/interest-rates/libor.aspx

[ghmm]

The proxy is up. Just scanned the materials but a couple of things of interest.
1-Loan terms LIBOR + 3.25 or 3.75 (depending on debt to EBITDA ratio), minimum rate 4.75.
2-It looks like the company approached Uniinvest and NOT the other way around.

After a detailed analysis, our
management concluded that repurchasing Uniinvest's shares at a moderate premium to the trading price of
our common shares would be highly accretive to our earnings per share. In this regard, management also
determined that the Repurchase could be financed at currently attractive interest rates so that a substantial
portion of the debt could be repaid through the application of cash that would otherwise be paid to
Uniinvest as dividends on the Shares. Management also was concerned that the possession of such a
large block of our common shares by an insolvent shareholder posed the risk of a transfer of that block to
a third party, potentially a competitor, and that the resulting change in control might not be beneficial to
our shareholders and employees.

3-Creditors right to bid higher for shares (though rarely exercised)
4-Board voted 4-1 to approve repurchase, the descent resigned right after.

The SEDAR link for the documents is below for those interested:
http://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00005373

[breeze101]

Just checked the board today, and people are really starting to talk about unilens. I did talk to the CFO after the buyback was announced and they are not disclosing the interest rate terms on the loan. He did however mention they got a good rate and had several banks willing to make them the loan. It is not such a big issue for me anyways.

Ive tried so many screeners and most of them give the same results over and over.

I dont remember where i found unilens, but i've noticed it usually isnt displayed in screen results ive been running. So it makes me think there are some other great values out there hiding that i can t find.

Im mostly looking for OTC and pink sheets, ive already been over everything on the nasdeq and amx and have found some pretty good values such as CAW.


Ive just got a feeling there may be even better stuff hiding in the ocscurity of the pink sheets otc market.

And yes i usually look for a dividend, first of all the income helps the return on the stock, second the dividend indicates to me a shareholder friendly management and stable earnings.

[MikeDDKing]

UVICF is now included in the SwingTrade portfolio:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43859813

[ghmm]

I like having Unilens in my portfolio and am looking forward to good things (aside from the nice dividend) in the coming years. It appears that we may be appearing on the radar/screeners of some people. Loooks like their is a bid of 40k shares now.

As far as screeners. I use Google's, Yahoo's and some of the brokers. Haven't found any one I love and usually I have to screen the results of each as the returned results aren't up-to-date.

What type of stocks are you looking for? High yield or just OTC/pink sheets in general?

[breeze101]

Hard to find any as good as UVICF

This is the largest holding I own. I cannot buy any more because I dont want to put all eggs in the unilens basket. Would like to find a good stock screener for OTC and pink sheets listings and find more like this company.

Anybody know any?

[ghmm]

Some decent sized volume today. Surprised no big price move either way. I was able to get a fair amount of stock a little bit ago too without stock moving much for what its worth.

Whoever the new shareholder(s) are welcome. Hopefully the buyback closes without a hitch in January and then I imagine we will be popuping more on people's radar/screens.

[ghmm]

Just noticed in CTIB's Q that there appears to be 0 amount recovered in the quarter from the former Employee. Thanks for pointing it out the possibility of that on the Motherboard I don't like companies hiding things like that but as far as grievous things that isn't as bad as other things.

The stock IMO appears fairly cheap by historical standards. I'ld like to see them keep reducing the debt though.

Disclosure: I have a small position.

[Knowledge is King]

Thanks again, ghmm

[ghmm]

My concern was the dividend would go too. But said with the tax benefit they'll still have about a million in savings (not paying the dividend on 2 million+ shares).

No I didn't ask about that, but I asked about conference calls and that is when he said about more visibility after January sometime.

[Knowledge is King]

Wow, thanks for the update!


I thought for sure they'd slash the dividend to pay off the debt faster. So now we're looking at a medical stock with a yield >10% and which will sport a P/E of less than 5 after those shares are bought back! I do wish they'd drop the "F" from their symbol and go all-American...did you discuss that possibility with management at all?

[ghmm]

To me this is a great deal for improving shareholder value!

I spoke with the company. Dividend not affected by deal. Still open to acquisitions. Royalty goes out to at least 2016. Look for more visibility next year.

I added to my position today for what its worth. Even after the foreign tax withholding (which you can get most of back) this is a great yield compared to nothing in a savings account surpised there isn't more interst in companies like this and CHKE.

[yielddude]

jasonak,
Yes, they are being purchased and takien out of circulation (reducing the float). I's good news, as I believe many investors were worried those shares would be dumped on the market at some point, as the company holding them was going through bankruptcy proceedings. I wish I was still holding my old shares now, but lost patience many months ago.

[jasonak]

Today's PR has me a little perplexed. Are the 2.1m shares being purchased and then retired?

What is everyone and anyone's take on this deal?

Thanks.

[Knowledge is King]

Even at a P/E of 10, the yield would still be about 10%!

[beigledog]

Can we at least get a 10 PE? They continue to do very well.

[Knowledge is King]

UVICF reports $.10 vs $.08


(COMTEX) B: Unilens Vision Reports Record Third Quarter Revenue, and Royal
ty Income ( PR Newswire )
B: Unilens Vision Reports Record Third Quarter Revenue, and Royalty Income ( PR
Newswire )

LARGO, Fla., May 27, 2009 /PRNewswire-FirstCall via COMTEX/ --
Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI),
which develops, licenses, manufactures, distributes and markets specialty
contact lenses, today reported its operating results for the third quarter
ended March 31, 2009 (FY2009).

Net sales, excluding royalty income, increased 2% to $1,701,043 in the
FY2009 third quarter, compared with $1,668,397 in the previous year third
quarter (FY2008). The increase was primarily a result of continued growth of
the Company's C-Vue brand disposable specialty contact lenses, sold
exclusively to licensed eye care professionals.

FY2009 third quarter net income was $446,850, compared with $368,730 in the
previous year third quarter, an increase of 21%.

Royalty income for the FY2009 third quarter increased 16.7% to a record
third quarter of $734,249 compared with $628,993 in the prior-year quarter.
Sales of licensed products by our licensee Bausch & Lomb continue to
increase, resulting in continued royalty income growth.

FY2009 third quarter income before taxes increased 18.1% to a record third
quarter of $745,249 compared with $631,193 in the prior-year quarter. After
recording net income tax expense of $298,399, Unilens reported net income of
$446,850 for the quarter, or $0.10 per diluted share. In the FY2008 third
quarter, the Company reported net income of $368,730, or $0.08 per diluted
share, which included income tax expense of $262,463.

"We are very pleased with our third quarter results, considering the current
economic environment," stated Michael J. Pecora, Chief Executive Officer of
Unilens Vision Inc. "Double-digit growth from our C-Vue brand of lenses sold
exclusively to independent practitioners, combined with a 17% growth in
royalty revenue derived from Bausch & Lomb's sales of multifocal lenses that
use our key technologies, was responsible for our record performance."

"I am also pleased to report that the Unilens' Board of Directors declared
its regular quarterly dividend of US $0.09 per common share, payable
tomorrow, May 28, 2009. "This decision was based on the Company's strong
balance sheet, and projected operating cash flows and is consistent with the
Board's commitment that shareholders should share directly in the earnings
achieved by management while continuing to execute our growth strategy,"
concluded Mr. Pecora.

For the nine months ended March 31, 2009, net sales excluding royalty
income, increased 2.9% to $4,992,811, as compared to $4,854,119 for the
prior-year nine months. Net sales of the Company's C-Vue brand disposable
contact lenses increased approximately 11% during the first nine months of
fiscal year 2009, while sales of replacement products lines declined, as
expected.

Net Income for the nine months increased 13.4% to $1,272,162, or $0.28 per
diluted share, compared with $1,121,941, or $0.25 per diluted share in the
prior-year 9 months.

Royalty income for the nine months ended March 31, 2009 increased 11.9% to a
record $2,114,215, compared with $1,888,641 in the prior-year 9 months,
demonstrating continued demand for sales of licensed products by our licensee
Bausch & Lomb.

Income before taxes for the nine months ended March 31, 2009 increased 18.5%
to $2,120,225, compared with $1,789,951 in the prior-year 9 months. After
recording net income tax expense of $848,063, Unilens reported net income of
$1,272,162, or $0.28 per diluted share, for the nine months ended March 31,
2009. This compared with net income of $1,121,941, or $0.25 per diluted
share, in the prior-year 9 months of fiscal year 2008, which included net
income tax expense of $668,010.

About Unilens Vision Inc. - "The Independent Eye Care Professionals Contact
Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned
subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses,
manufactures, distributes and markets contact lenses primarily under the
C-Vue brand directly to Independent Eye Care Professionals. Additional
information on the Company may be accessed on the Internet at
www.unilens.com. The Company's common stock is listed on the OTC Bulletin
Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange
under the symbol "UVI".

(Note: All financial information in this release is stated in U.S. Dollars.)

The information contained in this news release, other than historical
information, consists of forward-looking statements that involve risk and
uncertainties that could cause actual results to differ materially from those
described in such statements. For a discussion of certain factors that could
cause actual results to differ materially from those described in the
forward-looking statements, please refer to the Company's most recent filings
with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not
reviewed and does not accept responsibility for the adequacy or accuracy of
this release.

For more information, please contact:

Leonard F. Barker, CFO, Unilens Vision Inc. at [phone]
UNILENS VISION INC.
THIRD QUARTER - FISCAL 2009
CONDENSED CONSOLIDATED FINANCIAL INFORMATION
(All figures in U.S. Dollars)
RESULTS OF OPERATIONS
Three Months Three Months Nine Months Nine Months
Ended Ended Ended Ended
March 31, March 31, March 31, March 31,
2009 2008 2009 2008
Sales $1,701,043 $1,668,397 $ 4,992,811 $4,854,119
Cost of sales 943,931 964,952 2,752,561 2,754,802
757,112 703,445 2,240,250 2,099,317
Expenses 731,093 706,041 2,206,395 2,176,183
Income (loss)
from operations 26,019 (2,596) 33,855 (76,866)
Other items:
Royalty income 734,249 628,993 2,114,215 1,888,641
Other (expense)
income (12,917) 1,845 (19,406) (47,071)
Remeasurement
(expense) income (2,479) (1,044) (11,463) 1,968
Interest income 377 3,995 3,024 23,279
719,230 633,789 2,086,370 1,866,817
Income before
income tax expense 745,249 631,193 2,120,225 1,789,951
Income tax expense 298,399 262,463 848,063 668,010
Net income for
the period $446,850 $368,730 $1,272,162 $1,121,941
Net income per
common share:
Basic $0.10 $0.08 $0.28 $0.25
Diluted $0.10 $0.08 $0.28 $0.25
CASH FLOWS
Provided (used) by:
Operating
activities $960,719 $893,412 $2,255,774 $1,848,658
Investing
activities (264,083) (33,699) (329,144) (63,458)
Financing
activities (409,565) (409,564) (2,593,908) (2,563,136)
Decrease in cash $287,071 $450,149 $(667,278) $(777,936)
BALANCE SHEET
June 30, March 31, March 31,
2008 2009 2008
Cash and certificate
of deposit $1,603,476 $1,174,735 $1,185,744
Total assets 6,784,128 5,529,389 6,489,924
Current liabilities 957,434 1,024,441 762,316
Total liabilities 957,434 1,024,441 762,316
Stockholders' equity $5,826,694 $4,504,948 $5,727,608

SOURCE Unilens Vision Inc.
http://www.unilens.com
Copyright (C) 2009 PR Newswire. All rights reserved
*** end of story ***

[xrymd]

The canadian government takes about a third out (I assume for taxes in canada.) You do get a credit on your income taxes for it.

[beigledog]

Nope...I live in NY

[xrymd]

The candian government takes a significant withholding. You must be from Canada.

[beigledog]

What haircut?

I get my $.09 every quarter.

[xrymd]

It may be the haircut you get from the candian government on the dividend. Plus it barely trades.

[Knowledge is King]

UVICF declares regular $.09 quarterly divi


why this stock is below $3 is a mystery...great growth, low P/E, and a 12% yield!



(PR Wires) PRW: Unilens Vision Inc. Declares Regular Quarterly Cash Dividend
of U.S. $0.09 Per Share
PRW: Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09
Per Share


Quarterly Cash Dividend Provides An Annualized Yield Of 13%

LARGO, Fla., May 1 /PRNewswire-FirstCall/ -- The Unilens Vision Inc. (OTC
Bulletin Board: UVICF) (TSX Venture Exchange: UVI) Board of Directors today
declared its regular quarterly cash dividend of U.S. $0.09 per common share,
payable May 28, 2009 to stockholders of record at the close of business on
May 14, 2009.

"We are pleased to continue the U.S. $0.09 per share quarterly dividend, which
on a annualized dividend rate of U.S. $0.36 per share provides a dividend
yield of 13% based on the closing price of our common stock in the U.S. on
Thursday April 30, 2009," stated Michael J. Pecora, Chief Executive Officer
of Unilens Vision Inc.

About Unilens Vision Inc. - "The Eye Care Professionals Specialty Contact Lens
Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary
Unilens Corp., USA, located in Largo, Florida, develops, licenses,
manufactures, distributes and markets contact lenses primarily under the
C-Vue brand directly to Independent Eye Care Professionals. Additional
information on the Company may be accessed on the Internet at
www.unilens.com. The Company's common stock is listed on the OTC Bulletin
Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange
under the symbol "UVI."

(Note: All financial information in this release is stated in U.S. Dollars.)

The information contained in this news release, other than historical
information, consists of forward-looking statements that involve risk and
uncertainties that could cause actual results to differ materially from
those described in such statements. For a discussion of certain factors
that could cause actual results to differ materially from those described in
the forward-looking statements, please refer to the Company's most recent
filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange
has not reviewed and does not accept responsibility for the adequacy or
accuracy of this release.

For more information, please contact:

Leonard Barker CFO, Unilens Vision Inc. at [phone]

SOURCE Unilens Vision, Inc.

/CONTACT: Leonard Barker CFO, Unilens Vision Inc., [phone]
/Web site: http://www.unilens.com

(END) Dow Jones Newswires
May 01, 2009 11:29 ET (15:29 GMT)
*** end of story ***

[beigledog]

Unilens Vision Reports Record Second Quarter Revenue, and Royalty Income

24th Consecutive Profitable Quarter Earns $.08 Per Diluted Share

LARGO, Fla., Feb. 26 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter ended December 31, 2008 (FY2009).

Net sales, excluding royalty income, increased 1.2% to $1,530,242 in FY2009 second quarter, compared with $1,512,361 in the previous year second quarter (FY2008). The increase was primarily a result of continued growth of the Company's C-Vue brand disposable specialty contact lenses, sold exclusively to licensed eye care professionals.

FY2009 second quarter net income was $358,945, compared with $375,915 in the previous year second quarter. Excluding a one-time favorable tax adjustment of $44,422 in the previous year second quarter, FY2009 second quarter net income increased 8.3%.

Royalty income for the FY2009 second quarter increased 3.0% to a record second quarter of $666,569 compared with $646,849 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued royalty income growth.

FY2009 second quarter income before taxes increased 11.9% to a record second quarter of $606,717 compared with $542,257 in the prior-year quarter. After recording net income tax expense of $247,772, Unilens reported net income of $358,945 for the quarter, or $0.08 per diluted share. In the FY2008 second quarter, the Company reported net income of $375,915, or $0.08 per diluted share, which included income tax expense of $166,342.

"We are very pleased with our second quarter results, considering the current economic environment," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc. "Double-digit growth from our C-Vue brand of lenses sold exclusively to independent practitioners, combined with a 3% growth in royalty revenue derived from Bausch & Lomb's sales of multifocal lenses that use our key technologies, was responsible for our record performance."

"I am also pleased to report that the Unilens Board of Directors declared its regular quarterly dividend of US $0.09 per common share, payable this Friday, February 27, 2009. "This decision was based on the Company's strong balance sheet, and projected operating cash flows and is consistent with the Board's commitment that shareholders should share directly in the earnings achieved by management while continuing to execute our growth strategy," concluded Mr. Pecora.

For the six months ended December 31, 2008, net sales excluding royalty income, increased 3.3% to $3,291,768, as compared to $3,185,722 for the prior-year six months. Net sales of the Company's C-Vue brand disposable contact lenses increased approximately 11.3% during the first half of fiscal year 2009, while sales of replacement products lines declined, as expected.

Net Income for the six months increased 9.6% to $825,312, or $0.18 per diluted share, compared with $753,211, or $0.17 per diluted share in the prior-year 6 months.

Royalty income for the six months ended December 31, 2008 increased 9.6% to a record $1,379,966, compared with $1,259,648 in the prior-year 6 months, demonstrating continued demand for sales of licensed products by our licensee Bausch & Lomb.

Income before taxes for the six months ended December 31, 2008 increased 18.7% to $1,374,976, compared with $1,158,758 in the prior-year 6 months. After recording net income tax expense of $549,664, Unilens reported net income of $825,312, or $0.18 per diluted share, for the six months ended December 31, 2008. This compared with net income of $753,211, or $0.17 per diluted share, in the prior-year 6 months of fiscal year 2008, which included net income tax expense of $405,547.

[yielddude]

Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per ShareLast update: 2/2/2009 10:58:00 AMQuarterly Cash Dividend Provides an Annualized Yield of 12% LARGO, Fla.,

Feb 02, 2009 /PRNewswire-FirstCall via COMTEX/ -- The Unilens Vision Inc. (OTC Bulletin Board: UVICF) (TSX Venture Exchange: UVI) Board of Directors today declared its regular quarterly cash dividend of U.S. $0.09 per common share, payable February 27, 2009 to stockholders of record at the close of business on February 13, 2009. "We are pleased to continue the U.S. $0.09 per share quarterly dividend, which on a annualized dividend rate of U.S. $0.36 per share provides a dividend yield of 12% based on the closing price of our common stock in the U.S. on Friday January 30, 2009", stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc.

About Unilens Vision Inc. - "The Eye Care Professionals Specialty Contact Lens Company" Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue(R) brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at . The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange under the symbol "UVI".

[ghmm]

I see a 20-f is out but didn't notice anything in skimming it (no mention of the deal that I could find). Whats with the volume today?

[ghmm]

I was waiting for a filing to see the size of the deal but haven't seen anything. Does anyone know? What about the dividend will they cut it to pay for the deal?

[beigledog]

Unilens Vision Acquires Aero Contact Lens, Inc.
Tuesday December 9, 12:23 pm ET


LARGO, Fla., Dec. 9 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the acquisition of the specialty gas permeable contact lens manufacturer Aero Contact Lens, Inc. located in Michigan.

Under the terms of the agreement, Unilens acquired certain assets of Aero Contact Lens, Inc. including regulatory approvals, customer lists, trade names and various other resources. The gas permeable Aero Contact Lens Brands acquired through the asset purchase include the V/X Multifocal, the Aspirations Multifocal and the R-2000 Keratoconus Lens. The lenses will be manufactured and marketed by Unilens under their pre-existing product brand names from the Unilens Corp., USA headquarters and manufacturing facility located in Largo, Florida.

Unilens will continue the Aero Contact Lens tradition of excellent customer service and consultation from the Aero Michigan office and current Aero pricing and policy programs will stay in effect to ensure a smooth transition.

"Here at Unilens, known in the industry as 'The Independent Eye Care Professional's Specialty Contact Lens Company,' we have a longstanding commitment to support the growth and strength of high quality independent optometry with some of the best contact lens technology available in the industry today," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "That is why we are so excited to have the Aero Contact Lens Brands as the newest additions to our ever expanding product portfolio that contribute directly to the patient retention and practice profitability of independents across the country. This acquisition, along with the recent launch of the C-Vue® Advanced Custom Toric and the C-Vue 1 Day daily disposable, illustrate Unilens' commitment to support independent eye care professionals throughout the U.S.," continued Pecora.

[beigledog]

Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income
Friday November 21, 9:01 am ET
Earnings Escalate 24% to $0.10 Per Share


LARGO, Fla., Nov. 21 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the first quarter ended September 30, 2008 (FY2009).

Net sales, excluding royalty income, increased 5.3% to $1,761,526 in FY2009 first quarter, compared with $1,673,361 in the previous year first quarter (FY2008). The increase was primarily a result of continued growth of the Company's C-Vue brand of specialty contact lenses, sold exclusively to licensed eye care professionals.

FY2009 first quarter net income increased 23.6% to a record first quarter of $466,367, or $.10 per diluted share, compared with $377,296 or $0.08 per diluted share in the previous year quarter.

Royalty income for the FY2009 first quarter increased 16.4% to a record first quarter of $713,397 compared with $612,799 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued double-digit royalty income growth.

FY2009 first quarter income before taxes increased 24.6% to a record first quarter $768,259 compared with $616,501 in the prior-year quarter. After recording net income tax expense of $301,892, Unilens reported net income of $466,367 for the quarter, or $0.10 per diluted share. In the FY2008 first quarter, the Company reported net income of $377,296, or $0.08 per diluted share, which included income tax expense of $239,205.

"We are pleased to report record first quarter sales, royalties and income for our FY2009 first quarter," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc. "Strong double-digit growth for our C-Vue brand of lenses sold exclusively to independent practitioners, combined with a 16% growth in royalty revenue derived from Bausch & Lomb's sales of multifocal lenses that use our key technologies, was responsible for this outstanding performance."

"I am also pleased to report that the Unilens' Board of Directors declared its regular quarterly dividend of US $0.09 per common share, payable next Friday November 28, 2008. "This decision was based on the Company's strong balance sheet, and projected operating cash flows and is consistent with the Board's commitment that shareholders should share directly in the earnings achieved by management while continuing to execute our growth strategy," concluded Mr. Pecora.

[xrymd]

I am the one with the bid of 2.71 but when I am done filling someone else needs to step up and keep the share price near $3

[SSKILLZ1]

Entered UVICF.OB today, thankfully someone grew Impatient and sold to me at $3.039. Thank you to whoever did it, you made my day.

[beigledog]

Thank you to whoever painted the tape today!

[beigledog]

Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens
Wednesday November 5, 4:59 pm ET
All New C-VUE Advanced Custom Toric Lens Now Available Through Licensed Eye Care Professionals Only


LARGO, Fla., Nov. 5 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of the all new C-VUE® Advanced(TM) Custom Toric. The C-VUE Advanced Custom Toric will be sold directly to independent eye care professionals and features a revolutionary trial program, an advanced hydration material and exceptional deliverability (typically ships within in 2 to 3 days).
ADVERTISEMENT


C-VUE Advanced Custom Toric is available in new convenient blister packaging with hioxifilcon D, a material which offers advanced hydration properties that allow it to retain 97% of its moisture resulting in all day comfort. The new product offering and hassle free trial/no returns necessary program will provide independent practitioners with an additional specialty C-VUE contact lens option that contributes to patient retention and practice profitability.

C-VUE Advanced Custom Toric is an easy to fit specialty toric contact lens, designed in an extremely wide range of customizable parameters with exceptional deliverability. The lens offers made to order base curves, diameters, powers and cylinders combined with axis in one degree steps.

"The launch of the C-VUE Advanced Custom Toric continues our tradition of providing outstanding specialty lens technology exclusively to licensed optical professionals," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "With our revolutionary Free Trial Program for custom lenses, we eliminate the time and expense of returning lenses, thereby increasing profitability to the Independent Eye Care Professional as well," concluded Mr. Pecora.

[Knowledge is King]

UVICF declares regular $.09 quarterly divi


why this thing still trades in the low-$3s I have no idea!


(PR NEWSWIRE) Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U
S. $0.09 Per Share
Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per S
are

LARGO, Fla., Nov. 3 /PRNewswire-FirstCall/ -- The Unilens Vision Inc. (OTC
Bulletin Board: UVICF) (TSX Venture Exchange: UVI) Board of Directors today
declared its regular quarterly cash dividend of U.S. $0.09 per common share,
payable November 28, 2008 to stockholders of record at the close of business
on November 14, 2008.
"We are pleased to continue the U.S. $0.09 per share quarterly dividend,
which on a annualized dividend rate of U.S. $0.36 per share provides a
dividend yield of 9.0% based on the closing price of our common stock in the
U.S. on Friday October 31, 2008," stated Michael J. Pecora, Chief Executive
Officer of Unilens Vision Inc.
About Unilens Vision Inc. -- "The Eye Care Professionals Specialty Contact
Lens Company"
Established in 1989, Unilens Vision Inc., through its wholly owned
subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses,
manufactures, distributes and markets specialty contact lenses under the
C-Vue, Unilens, Sof-Form, Aquaflex, SoftCon, Lombart, and LifeStyle brands.
Additional information on the Company may be accessed on the Internet at
http://www.unilens.com . The Company's common stock is listed on the OTC
Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture
Exchange under the symbol "UVI".
(Note: All financial information in this release is stated in U.S.
Dollars.)
The information contained in this news release, other than historical
information, consists of forward-looking statements that involve risk and
uncertainties that could cause actual results to differ materially from those
described in such statements. For a discussion of certain factors that could
cause actual results to differ materially from those described in the
forward-looking statements, please refer to the Company's most recent filings
with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not
reviewed and does not accept responsibility for the adequacy or accuracy of
this release.
For more information, please contact:
Leonard Barker CFO, Unilens Vision Inc. at [phone]
SOURCE Unilens Vision Inc.


Contact Information:
Leonard Barker CFO of Unilens Vision Inc., [phone]

WebSite:
http://www.unilens.com
*** end of story ***

[yielddude]

Some snippets from annual report(6K) ...

8. OPERATING LEASES (they will be reducing their rent payments)

The Company leases, through Unilens Corp. USA, a combined office and manufacturing facility in Largo, Florida and a sales office in Clearwater, Florida. The Largo lease agreement, which is guaranteed by the Company, provides for escalation of rental payments based on taxes and increases in the Consumer Price Index. The lease term is through September 30, 2008 and calls for approximate monthly rental payments of $18,448. The Clearwater lease agreement calls for approximate monthly rental payments of $2,950, with an escalation of rental payments based on increases in the landlord’s operating expenses, utility costs and real estate taxes. The lease term is through May 31, 2009.

During the fourth quarter of fiscal year 2008, the Company negotiated a new Largo lease agreement. Effective July 1, 2008 the new five-year lease agreement, calls for approximate monthly rental payments of $16,261, and provides for escalation of rental payments in years four and five. The new lease term is through June 30, 2013 with a five-year option. If there is a change of control of the Company after June 30, 2010, the new lease can be terminated by the Company with four and one half months written notice, and under certain conditions maybe subject to three months liquidating damages.

(Here they give positive guidance, but also mention the possibility of change of control, as largest shareholder going thru bankruptcy. This is not new info, but it seems a little more detailed than in the past...)
As of June 30, 2008, the deferred tax asset is primarily the result of net operating loss carryforwards which are available in future years to offset taxable income. Realization of that asset is dependent on the Company, generating future taxable income against which its loss carryforwards can be offset before they expire. The Company estimated its future taxable income for the next ten fiscal years, assuming improvements over current levels of pretax income. It then compared its projected taxable income against its net operating loss schedule and determined an allowance against the deferred tax asset was not necessary. Based on all positive and negative evidence available, including sales trends and outlook data, the Company believes it is more likely than not that it will be able to increase its current level of taxable income, thereby fully realizing its deferred tax asset relating to its United States activity recorded at June 30, 2008. An allowance could be required if near-term estimates of future taxable income during the carryforward periods are changed. Utilization of the deferred tax asset may be subject to limitations in the event of significant changes in the beneficial ownership of the Company’s shares. The Company cannot predict if or when such changes might occur, or their effect, if any, on the deferred tax asset, which will be dependent on such factors as the size of the beneficial ownership change, its timing and the prices at which shares involved in the change are disposed. The Company is aware, however, that its largest shareholder is the subject of bankruptcy proceedings that conceivably could result in such shareholder’s disposition of all or a portion of its Company shares.

Outlook

We anticipate continued growth of our C-Vue brand of disposal specialty contact lenses to independent eye care professionals. We believe market demographics favoring specialty contact lenses will continue to drive our revenue and earnings growth. Over the next year we plan on adding new contact lens products to our C-Vue brand, such as custom lenses in higher oxygen permeable materials.

[beigledog]

Here's the PR:

Unilens Vision Reports Record Revenue, Pretax Earnings and Royalty Income for Year Ended June 30, 2008
Tuesday September 30, 4:32 pm ET
EARNINGS ESCALATE OVER 24% TO $0.36 PER SHARE

LARGO, Fla., Sept. 30 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the fourth quarter and fiscal year ended June 30, 2008 (FY2008).

Net sales, excluding royalty income, increased 4.6% to $6,665,566 in FY2008, compared with $6,370,930 in the previous fiscal year (FY2007). The increase was primarily a result of continued growth of the Company's C-Vue brand of specialty contact lenses, sold exclusively to licensed eye care professionals.

Royalty income for FY2008 increased 20.0% to a record $2,629,123 compared with $2,190,428 in the prior-year. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued double digit royalty income growth and record royalty payments.

FY2008, income before taxes increased 21.0% to a record $2,636,652 compared with $2,179,742 in the prior-year. After recording net income tax expense of $1,006,060, Unilens reported net income of $1,630,592 for the year, or $0.36 per diluted share. In FY2007, the Company reported net income of $1,309,961, or $0.29 per diluted share, which included income tax expense of $869,781.

"We are pleased to report record sales, royalties and pretax income for the year ended June 30, 2008," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc. "Strong double-digit growth for our C-Vue brand of lenses sold exclusively to independent practitioners, combined with a 20% growth in royalty revenue derived from Bausch & Lomb's sales of multifocal lenses that use our key technologies, was responsible for this outstanding performance."

For the fourth quarter ended June 30, 2008, net sales excluding royalty income, increased 7.0% to $1,811,447, as compared to $1,693,572 for the fourth quarter ending June 30, 2007. Net sales of the Company's C-Vue disposable multifocal contact lenses increased by 11% during the fourth quarter of FY2008, while sales of conventional product lines declined, as expected.

Royalty income for the fourth quarter ended June 30, 2008 increased 17.4% to a record $740,482, compared with $630,932 in the prior-year period, demonstrating increasing demand for sales of licensed products by our licensee Bausch & Lomb.

Income before taxes for the fourth quarter ended June 30, 2008 increased 26.3% to $846,701, compared with $670,471 in the prior-year period. After recording net income tax expense of $338,050, Unilens reported net income of $508,651, or $0.11 per diluted share, for the quarter ended June 30, 2008. This compared with net income of $406,264, or $0.09 per diluted share in the fourth quarter of FY2007, which included income tax expense of $264,207.

"Our financial condition at the end of the most recent fiscal year continues to be strong. After paying out over $3.0 million in cash dividends during FY2008, we remain debt free, with a cash position of $1.6 million, as of June 30, 2008," stated Michael Pecora.

Shortly after the end of our fiscal year, the Unilens' Board of Directors declared a third special cash dividend of US $0.30 per common share and its regular quarterly dividend of US $0.09 per common share. "This decision was based on the Company's strong balance sheet, and projected operating cash flows and is consistent with the Board's commitment that shareholders should share directly in the earnings achieved by management while continuing to execute our growth strategy."

[MikeDDKing]

Very nice report!

Mike

[ghmm]

Well they did exactly like they said (little better). Wish I had gotten more.

http://biz.yahoo.com/prnews/080930/cltu112.html?.v=76

Does anyone know if the spread tends to tighten on news/earnings?

[ghmm]

Royalty Question?

I love the royalty even though it is just 3-5% it is a great revenue stream with no overhead! I have a question hope someone may have more background. Does anyone know how safe it is, more specifically how long it goes out (till patent(s) expire?) and how much risk is there that B&L stops selling product(s) using it. TIA

[MikeDDKing]

Unilens Vision Expects to Report Record Royalty Income and Escalating Earnings for Fourth Quarter and Fiscal Year
Wednesday August 27, 9:00 am ET


LARGO, Fla., Aug. 27 /PRNewswire-FirstCall/ -- Unilens Vision Inc. today announced that the Company expects to report record royalty income and increased earnings for the quarter and fiscal year ended June 30, 2008. Detailed audited results with comparative data will be released on or before September 30, 2008.

"Based upon information currently available, we expect to report fully diluted earnings per share of at least $0.35 for Fiscal Year 2008, on record net sales of slightly more than $6.6 million, excluding royalty income," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "Fourth quarter earnings per share should reach or exceed $0.10 per diluted share."

"We are very pleased with the Company's results during the most recent fiscal year," continued Pecora. "Strong double-digit growth for our C-Vue brand of lenses sold exclusively to independent practitioners, combined with a 20% growth in royalty income derived from the license of our key technologies, were responsible for this outstanding performance."

About Unilens Vision Inc. -- "The Independent Eye Care Professionals Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue® brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange under the symbol "UVI."

Note: All financial information in this release is stated in U.S. Dollars.

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risk and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward- looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Leonard F. Barker, CFO, Unilens Vision Inc. at [phone]




--------------------------------------------------------------------------------
Source: Unilens Vision Inc.

[beigledog]

UVICF...another special dividend!

Unilens Vision Inc. Declares Special Cash Dividend of US $0.30 Per Share
Friday August 1, 9:00 am ET
Regular Quarterly Cash Dividend of US $0.09, Provides an Annualized Yield of 10.7%


LARGO, Fla., Aug. 1 /PRNewswire-FirstCall/ -- The Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News) Board of Directors today declared its third consecutive special cash dividend and its eighth consecutive quarterly dividend. The special cash dividend of US $0.30 per common share and its regular quarterly dividend of US $0.09 per common share are both payable August 28, 2008 to stockholders of record at the close of business on August 14, 2008.

The regular quarterly dividend of US $0.09 per share, which on an annualized basis of US $0.36 per share provides a dividend yield of 10.7% based on the closing price of our common stock in the U.S. on Thursday, July 31, 2008. The amount of future dividends will depend on earnings, cash flow, and all other aspects of our business as determined by the board of directors.

"The special and quarterly dividends are based on our strong balance sheet and projected significant operating cash flows," stated Michael J. Pecora, President and Chief Executive Officer of Unilens Vision Inc. "We are pleased to be in a position to return profits back to our shareholders while continuing to execute our growth strategy."

[yielddude]

It sounds like they are trying to increase volume and customer base. They just introduced some new products, and plan on introducing some more, so the more customers and the better customer service, would allow them to expand and expose more to these products. Is so, this should be successful.
If they did not increase volume or gain new clients, then it would increase their costs. I believe they used a similar strategy a couple years ago, when they discounted some of their lenses to achieve market penetration, and it worked. Hopefully this will also.
yield

[beigledog]

I'm not really sure how this will affect UVICF, but it doesn't really sound positive to me. It sounds like they would be getting less revenues for products that already don't earn anything in EBIT $$.

[beigledog]

Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability
Wednesday June 4, 9:15 am ET


LARGO, Fla., June 4 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today revealed a cutting edge program for all Unilens GP (Gas Permeable) products.

Unilens, known as the "Eye Care Professional's Specialty Contact Lens Company", continues its tradition of providing outstanding programs designed to increase the profitability and patient retention for independent practitioners by now eliminating processing and shipping costs on all Unilens GP exchange lens orders. The policy covers all Unilens single vision and multifocal GP contact lenses, including the C-VUE® GP brand that incorporates the same patented design technology, as the best selling Unilens C-VUE Soft Multifocal contact lens.

"At Unilens, we have a longstanding commitment to supporting the growth and strength of high quality independent optometry with some of the best specialty lens technology and dynamic programs available in the industry today. Our new GP policies will save independent practitioners considerable time and money, thereby contributing to more practice profitability," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "We look for this new program to continue to solidify our partnership with independent eye care professionals across the country," stated Pecora.

About Unilens Vision Inc. - "The Eye Care Professional's Specialty Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets specialty contact lenses under the C- Vue, Unilens, Sof-Form, Aquaflex, SoftCon, Lombart, and LifeStyle brands. Additional information on the Company may be accessed on the Internet at www.unilens.com .

For more information, please contact:

Kelly McKnight at [phone]

[beigledog]

Unilens Vision Reports Increased Royalty Income
Wednesday May 28, 9:15 am ET
21st Consecutive Profitable Quarter Earns $.08 Per Diluted Share


LARGO, Fla., May 28 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine months of FY2008.

Net sales, excluding royalty income, for the quarter ended March 31, 2008 increased to $1,668,397 compared with $1,634,429 in the prior-year quarter ending March 31, 2007 an increase of 2.1%. The increase was primarily the result of continued growth of the Company's C-Vue multifocal contact lenses, which increased approximately 11% in the current quarter, which was partially offset by sales of our replacement products lines that declined as expected.

Royalty income for the quarter increased 15.3% to $628,993 compared with $545,293 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued double digit royalty income growth.

For the quarter, the Company reported net income of $368,730, or $0.08 per diluted share, compared with net income of $372,355 or $0.08 per diluted share in the prior-year quarter.

For the nine months ended March 31, 2008, net sales excluding royalty income, increased 3.8% to $4,854,119 as compared to $4,677,358 for the prior- year period. Net sales of the Company's C-Vue multifocal contact lenses increased approximately 12% during the first nine months of fiscal year 2008, while sales of replacement products lines declined, as expected.

Net Income for the nine months increased 24.2% to $1,121,941, or $0.25 per diluted share, compared with $903,697, or $0.20 per diluted share in the prior-year period.

Royalty income for the nine months ended March 31, 2008 increased 21.1% to a record $1,888,641, compared with $1,559,496 in the prior-year period, demonstrating continued increased demand for sales of licensed products by our licensee Bausch & Lomb.

"We are pleased to report our 21st consecutive quarter of profitability driven by increased royalty income from Bausch and Lomb's multifocal sales utilizing our patented licensed technology," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc. "Sales of our C-Vue brand disposable multifocal and single vision lenses also continue to steadily increase, achieving double digit growth."

"Earlier this month, we added to our C-Vue brand with the launch of the C- Vue 1DAY daily disposable single vision lens. This new offering expands the Company's portfolio of soft lens products, serving the rapidly growing one- time use daily disposable single vision market," concluded Mr. Pecora. The Company will market the lens under the C-Vue brand exclusively to licensed eye care professionals.

[MikeDDKing]

Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens
Wednesday May 21, 9:15 am ET
C-VUE 1 Day ASV Single Vision Lens Now Available Through Licensed Eye Care Professionals Only


LARGO, Fla., May 21 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of the all new C-VUE® 1 Day ASV, which is the first aspheric, daily disposable contact lens sold under the C-VUE brand.

Unilens, known as the "Eye Care Professional's Specialty Contact Lens Company" continues its tradition of providing outstanding specialty lens solutions exclusively to licensed optical professionals by offering the new C-VUE 1 Day ASV (Aspheric Single Vision) lens as a daily disposable that is ideal for low level astigmats, early presbyopes, and those who simply wish to improve their vision. The new product offering will provide independent practitioners with an additional aspheric C-VUE contact lens option that contributes to patient retention and practice profitability.

C-VUE 1 Day ASV is an easy to fit contact lens, designed with aspheric optics that provides superb comfort and an improved depth of focus at all ranges. There is no required daily cleaning or care required. The lenses may be worn for a day and then just simply thrown away.

"With the continued success of our best selling C-VUE Multifocal lenses, C-VUE Toric Multifocal and C-VUE ASV we are now pleased to offer our very first daily disposable single vision solution with the C-VUE 1 Day ASV to licensed eye professionals only," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "This new offering expands the Company's portfolio of soft lens products, serving the rapidly growing one-time use daily disposable single vision market," concluded Mr. Pecora.

About Unilens Vision Inc. - "The Eye Care Professional's Specialty Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets specialty contact lenses under the C-VUE, Unilens, Sof-Form, Aquaflex, SoftCon, Lombart, and LifeStyle brands. Additional information on the Company may be accessed on the Internet at www.unilens.com.

The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the TSX Venture Exchange under the symbol "UVI".

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Kelly McKnight at [phone]




--------------------------------------------------------------------------------
Source: Unilens Vision Inc.

[MikeDDKing]

Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
Thursday May 1, 2:00 pm ET
Quarterly Cash Dividend Provides an Annualized Yield of 10.4%


LARGO, Fla., May 1 /PRNewswire-FirstCall/ -- The Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News) Board of Directors today declared its regular quarterly cash dividend of U.S. $0.09 per common share, payable May 28, 2008 to stockholders of record at the close of business on May 14, 2008.

"We are pleased to continue the U.S. $0.09 per share quarterly dividend, which on a annualized dividend rate of U.S. $0.36 per share provides a dividend yield of 10.4% based on the closing price of our common stock in the U.S. on Wednesday April 30, 2008," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc.

About Unilens Vision Inc. - "The Eye Care Professionals Specialty Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets specialty contact lenses under the C-Vue, Unilens, Sof-Form, Aquaflex, SoftCon, Lombart, and LifeStyle brands. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange under the symbol "UVI".

(Note: All financial information in this release is stated in U.S. Dollars.)

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risk and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.


For more information, please contact:
Leonard Barker CFO, Unilens Vision Inc. at [phone]



--------------------------------------------------------------------------------
Source: Unilens Vision Inc.